Trial Site Detail

 

Drug:
Imatinib, Nilotinib
Trial:
REGISTER: A multicentre phase 2 study of risk evaluation in GIST with selective therapy escalation for response
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Ongoing, but not recruiting

 

Peter McCallum Cancer Institute

10 St Andrews Place     
East Melbourne , Victoria 3002
Australia

 

Principal Investigator:
 Jayesh Desai, MD
Contact:
 10 St Andrews Pl, East Melbourne, VIC 3002, Australia
Activation Status of this Site:
 Closed
Notes about this Site:
Peter McCallum Cancer Institute Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.